Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
about
Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder.Combination treatments for overactive bladder refractory to first-line pharmacotherapy: do they meet expectations?Recent advances in pharmacological management of urinary incontinence.Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis.A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects: a report from the SYNERGY trial.
P2860
Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Efficacy and safety of combina ...... ctive bladder (SYNERGY study).
@en
type
label
Efficacy and safety of combina ...... ctive bladder (SYNERGY study).
@en
prefLabel
Efficacy and safety of combina ...... ctive bladder (SYNERGY study).
@en
P2093
P2860
P356
P1433
P1476
Efficacy and safety of combina ...... active bladder (SYNERGY study)
@en
P2093
Arwin Ridder
Asha Paireddy
Christopher R Chapple
David Mitcheson
Dudley Robinson
Matthias Stoelzel
Paul Abrams
Rob van Maanen
Salvador Arlandis
Sender Herschorn
P2860
P304
P356
10.1111/BJU.13882
P50
P577
2017-06-08T00:00:00Z